nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—SLC36A2—Amino acid transport across the plasma membrane—SLC6A6—coronary artery disease	0.0499	0.106	CbGpPWpGaD
Cycloserine—SLC36A2—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.0346	0.0734	CbGpPWpGaD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.0204	0.0432	CbGpPWpGaD
Cycloserine—Drug hypersensitivity—Clopidogrel—coronary artery disease	0.0194	0.0368	CcSEcCtD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	0.0121	0.0257	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—SOD1—coronary artery disease	0.0101	0.0214	CbGpPWpGaD
Cycloserine—Disorientation—Penbutolol—coronary artery disease	0.00992	0.0188	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	0.0091	0.0193	CbGpPWpGaD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	0.00907	0.0192	CbGpPWpGaD
Cycloserine—DDC—Dopamine metabolism—PPP2CA—coronary artery disease	0.00834	0.0177	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Ticagrelor—coronary artery disease	0.00816	0.0154	CcSEcCtD
Cycloserine—Coma—Acetylsalicylic acid—coronary artery disease	0.00815	0.0154	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—FEV—coronary artery disease	0.00798	0.0169	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—HADH—coronary artery disease	0.00738	0.0157	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.0069	0.0146	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.00661	0.014	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CAV3—coronary artery disease	0.00605	0.0128	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.00586	0.0124	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—CKMT1B—coronary artery disease	0.00585	0.0124	CbGpPWpGaD
Cycloserine—Osteoarthritis—Fenofibrate—coronary artery disease	0.00578	0.0109	CcSEcCtD
Cycloserine—Osteoarthritis—Clopidogrel—coronary artery disease	0.00568	0.0108	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—RAI1—coronary artery disease	0.00554	0.0118	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—ALDH2—coronary artery disease	0.00544	0.0115	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.00544	0.0115	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.00541	0.0115	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.00541	0.0115	CbGpPWpGaD
Cycloserine—Confusional state—Pitavastatin—coronary artery disease	0.0053	0.01	CcSEcCtD
Cycloserine—Cardiac failure congestive—Telmisartan—coronary artery disease	0.00502	0.0095	CcSEcCtD
Cycloserine—Drowsiness—Acetylsalicylic acid—coronary artery disease	0.00499	0.00944	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.00485	0.0103	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.00485	0.0103	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—CKM—coronary artery disease	0.00477	0.0101	CbGpPWpGaD
Cycloserine—Osteoarthritis—Trandolapril—coronary artery disease	0.00464	0.00877	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.00462	0.00981	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—BHLHE40—coronary artery disease	0.00459	0.00973	CbGpPWpGaD
Cycloserine—Osteoarthritis—Telmisartan—coronary artery disease	0.00455	0.00862	CcSEcCtD
Cycloserine—Hypersensitivity—Tirofiban—coronary artery disease	0.00454	0.00858	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—CKMT2—coronary artery disease	0.00443	0.0094	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—ALDH6A1—coronary artery disease	0.00443	0.0094	CbGpPWpGaD
Cycloserine—Feeling abnormal—Pitavastatin—coronary artery disease	0.00433	0.00819	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—KCNJ8—coronary artery disease	0.00419	0.0089	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CREM—coronary artery disease	0.00419	0.0089	CbGpPWpGaD
Cycloserine—Vertigo—Gemfibrozil—coronary artery disease	0.0041	0.00776	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.00405	0.0086	CbGpPWpGaD
Cycloserine—Vertigo—Ticagrelor—coronary artery disease	0.004	0.00758	CcSEcCtD
Cycloserine—Convulsion—Gemfibrozil—coronary artery disease	0.00395	0.00748	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—GATM—coronary artery disease	0.00395	0.00838	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.00388	0.00822	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.00388	0.00822	CbGpPWpGaD
Cycloserine—Hypersensitivity—Pitavastatin—coronary artery disease	0.00387	0.00733	CcSEcCtD
Cycloserine—Headache—Tirofiban—coronary artery disease	0.00386	0.0073	CcSEcCtD
Cycloserine—Disorientation—Timolol—coronary artery disease	0.00378	0.00715	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.00377	0.008	CbGpPWpGaD
Cycloserine—Confusional state—Gemfibrozil—coronary artery disease	0.00375	0.0071	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—BHLHE40—coronary artery disease	0.00374	0.00794	CbGpPWpGaD
Cycloserine—Cardiac failure congestive—Timolol—coronary artery disease	0.00373	0.00705	CcSEcCtD
Cycloserine—Confusional state—Ticagrelor—coronary artery disease	0.00367	0.00694	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—RYR2—coronary artery disease	0.00367	0.00778	CbGpPWpGaD
Cycloserine—Drowsiness—Trandolapril—coronary artery disease	0.00357	0.00676	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—ID3—coronary artery disease	0.00357	0.00758	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.0035	0.00743	CbGpPWpGaD
Cycloserine—Vertigo—Acetylsalicylic acid—coronary artery disease	0.0035	0.00662	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—CAT—coronary artery disease	0.00349	0.0074	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—YBX1—coronary artery disease	0.00348	0.00737	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CREM—coronary artery disease	0.00342	0.00726	CbGpPWpGaD
Cycloserine—Osteoarthritis—Timolol—coronary artery disease	0.00338	0.0064	CcSEcCtD
Cycloserine—Convulsion—Acetylsalicylic acid—coronary artery disease	0.00338	0.00639	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.00336	0.00713	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.00336	0.00713	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—CKB—coronary artery disease	0.00336	0.00712	CbGpPWpGaD
Cycloserine—Paraesthesia—Gemfibrozil—coronary artery disease	0.00334	0.00633	CcSEcCtD
Cycloserine—Rash—Pitavastatin—coronary artery disease	0.00331	0.00627	CcSEcCtD
Cycloserine—Drowsiness—Perindopril—coronary artery disease	0.00331	0.00627	CcSEcCtD
Cycloserine—Dermatitis—Pitavastatin—coronary artery disease	0.00331	0.00626	CcSEcCtD
Cycloserine—Somnolence—Gemfibrozil—coronary artery disease	0.00331	0.00626	CcSEcCtD
Cycloserine—Confusional state—Rosuvastatin—coronary artery disease	0.0033	0.00625	CcSEcCtD
Cycloserine—Headache—Pitavastatin—coronary artery disease	0.00329	0.00623	CcSEcCtD
Cycloserine—Paraesthesia—Ticagrelor—coronary artery disease	0.00327	0.00618	CcSEcCtD
Cycloserine—Drowsiness—Furosemide—coronary artery disease	0.00322	0.00609	CcSEcCtD
Cycloserine—Confusional state—Acetylsalicylic acid—coronary artery disease	0.00321	0.00607	CcSEcCtD
Cycloserine—Tremor—Lovastatin—coronary artery disease	0.00318	0.00603	CcSEcCtD
Cycloserine—Osteoarthritis—Lisinopril—coronary artery disease	0.00314	0.00593	CcSEcCtD
Cycloserine—Vertigo—Fenofibrate—coronary artery disease	0.00313	0.00592	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—MAPK14—coronary artery disease	0.00308	0.00652	CbGpPWpGaD
Cycloserine—Vertigo—Clopidogrel—coronary artery disease	0.00307	0.00582	CcSEcCtD
Cycloserine—Feeling abnormal—Gemfibrozil—coronary artery disease	0.00307	0.00581	CcSEcCtD
Cycloserine—Vertigo—Lovastatin—coronary artery disease	0.00305	0.00578	CcSEcCtD
Cycloserine—Feeling abnormal—Ticagrelor—coronary artery disease	0.003	0.00567	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.00298	0.00632	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.00298	0.00632	CbGpPWpGaD
Cycloserine—Tremor—Simvastatin—coronary artery disease	0.00298	0.00564	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HSP90B1—coronary artery disease	0.00296	0.00627	CbGpPWpGaD
Cycloserine—Paraesthesia—Rosuvastatin—coronary artery disease	0.00294	0.00556	CcSEcCtD
Cycloserine—Vertigo—Simvastatin—coronary artery disease	0.00286	0.00541	CcSEcCtD
Cycloserine—Somnolence—Acetylsalicylic acid—coronary artery disease	0.00283	0.00535	CcSEcCtD
Cycloserine—Confusional state—Clopidogrel—coronary artery disease	0.00282	0.00533	CcSEcCtD
Cycloserine—Confusional state—Lovastatin—coronary artery disease	0.0028	0.00529	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00275	0.00583	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00275	0.00583	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00275	0.00583	CbGpPWpGaD
Cycloserine—Confusional state—Ezetimibe—coronary artery disease	0.00274	0.00519	CcSEcCtD
Cycloserine—Headache—Penbutolol—coronary artery disease	0.00273	0.00517	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—NRIP1—coronary artery disease	0.00271	0.00574	CbGpPWpGaD
Cycloserine—Vertigo—Valsartan—coronary artery disease	0.0027	0.0051	CcSEcCtD
Cycloserine—Feeling abnormal—Rosuvastatin—coronary artery disease	0.0027	0.0051	CcSEcCtD
Cycloserine—Tremor—Pravastatin—coronary artery disease	0.00269	0.0051	CcSEcCtD
Cycloserine—Vertigo—Olmesartan—coronary artery disease	0.00268	0.00508	CcSEcCtD
Cycloserine—Hypersensitivity—Ticagrelor—coronary artery disease	0.00268	0.00507	CcSEcCtD
Cycloserine—Vertigo—Niacin—coronary artery disease	0.00262	0.00496	CcSEcCtD
Cycloserine—Feeling abnormal—Acetylsalicylic acid—coronary artery disease	0.00262	0.00496	CcSEcCtD
Cycloserine—Confusional state—Simvastatin—coronary artery disease	0.00262	0.00495	CcSEcCtD
Cycloserine—Tremor—Enalapril—coronary artery disease	0.0026	0.00493	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—UTS2R—coronary artery disease	0.0026	0.0055	CbGpPWpGaD
Cycloserine—Vertigo—Pravastatin—coronary artery disease	0.00258	0.00489	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HADHA—coronary artery disease	0.00257	0.00545	CbGpPWpGaD
Cycloserine—Paraesthesia—Fenofibrate—coronary artery disease	0.00255	0.00483	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—GCLM—coronary artery disease	0.00255	0.0054	CbGpPWpGaD
Cycloserine—Somnolence—Fenofibrate—coronary artery disease	0.00253	0.00478	CcSEcCtD
Cycloserine—Vertigo—Trandolapril—coronary artery disease	0.00251	0.00475	CcSEcCtD
Cycloserine—Paraesthesia—Clopidogrel—coronary artery disease	0.00251	0.00475	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—ADORA1—coronary artery disease	0.0025	0.0053	CbGpPWpGaD
Cycloserine—Vertigo—Enalapril—coronary artery disease	0.0025	0.00473	CcSEcCtD
Cycloserine—Paraesthesia—Lovastatin—coronary artery disease	0.00249	0.00471	CcSEcCtD
Cycloserine—Vertigo—Telmisartan—coronary artery disease	0.00246	0.00466	CcSEcCtD
Cycloserine—Paraesthesia—Ezetimibe—coronary artery disease	0.00244	0.00462	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.00243	0.00516	CbGpPWpGaD
Cycloserine—Tremor—Perindopril—coronary artery disease	0.00243	0.00459	CcSEcCtD
Cycloserine—Hypersensitivity—Rosuvastatin—coronary artery disease	0.00241	0.00456	CcSEcCtD
Cycloserine—Confusional state—Pravastatin—coronary artery disease	0.00237	0.00448	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.00236	0.00501	CbGpPWpGaD
Cycloserine—Rash—Gemfibrozil—coronary artery disease	0.00235	0.00444	CcSEcCtD
Cycloserine—Dermatitis—Gemfibrozil—coronary artery disease	0.00235	0.00444	CcSEcCtD
Cycloserine—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.00234	0.00443	CcSEcCtD
Cycloserine—Feeling abnormal—Fenofibrate—coronary artery disease	0.00234	0.00443	CcSEcCtD
Cycloserine—Headache—Gemfibrozil—coronary artery disease	0.00233	0.00441	CcSEcCtD
Cycloserine—Paraesthesia—Simvastatin—coronary artery disease	0.00233	0.00441	CcSEcCtD
Cycloserine—Vertigo—Perindopril—coronary artery disease	0.00233	0.0044	CcSEcCtD
Cycloserine—Feeling abnormal—Clopidogrel—coronary artery disease	0.0023	0.00435	CcSEcCtD
Cycloserine—Rash—Ticagrelor—coronary artery disease	0.00229	0.00434	CcSEcCtD
Cycloserine—Dermatitis—Ticagrelor—coronary artery disease	0.00229	0.00433	CcSEcCtD
Cycloserine—Confusional state—Enalapril—coronary artery disease	0.00229	0.00433	CcSEcCtD
Cycloserine—Feeling abnormal—Lovastatin—coronary artery disease	0.00229	0.00433	CcSEcCtD
Cycloserine—Headache—Ticagrelor—coronary artery disease	0.00228	0.00431	CcSEcCtD
Cycloserine—Tremor—Losartan—coronary artery disease	0.00228	0.00431	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—ARNTL—coronary artery disease	0.00227	0.00481	CbGpPWpGaD
Cycloserine—Vertigo—Furosemide—coronary artery disease	0.00226	0.00428	CcSEcCtD
Cycloserine—Feeling abnormal—Ezetimibe—coronary artery disease	0.00224	0.00424	CcSEcCtD
Cycloserine—Paraesthesia—Valsartan—coronary artery disease	0.0022	0.00416	CcSEcCtD
Cycloserine—Feeling abnormal—Eplerenone—coronary artery disease	0.00219	0.00415	CcSEcCtD
Cycloserine—Confusional state—Captopril—coronary artery disease	0.00219	0.00415	CcSEcCtD
Cycloserine—Vertigo—Losartan—coronary artery disease	0.00218	0.00413	CcSEcCtD
Cycloserine—Somnolence—Valsartan—coronary artery disease	0.00218	0.00412	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.00217	0.0046	CbGpPWpGaD
Cycloserine—Paraesthesia—Niacin—coronary artery disease	0.00214	0.00405	CcSEcCtD
Cycloserine—Feeling abnormal—Simvastatin—coronary artery disease	0.00214	0.00405	CcSEcCtD
Cycloserine—Confusional state—Perindopril—coronary artery disease	0.00213	0.00403	CcSEcCtD
Cycloserine—Somnolence—Niacin—coronary artery disease	0.00212	0.00401	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.00211	0.00448	CbGpPWpGaD
Cycloserine—Paraesthesia—Pravastatin—coronary artery disease	0.00211	0.00399	CcSEcCtD
Cycloserine—Hypersensitivity—Fenofibrate—coronary artery disease	0.00209	0.00396	CcSEcCtD
Cycloserine—Confusional state—Furosemide—coronary artery disease	0.00207	0.00392	CcSEcCtD
Cycloserine—Rash—Rosuvastatin—coronary artery disease	0.00206	0.00391	CcSEcCtD
Cycloserine—Dermatitis—Rosuvastatin—coronary artery disease	0.00206	0.0039	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.00206	0.00437	CbGpPWpGaD
Cycloserine—Hypersensitivity—Clopidogrel—coronary artery disease	0.00206	0.00389	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—UTS2—coronary artery disease	0.00205	0.00435	CbGpPWpGaD
Cycloserine—Headache—Rosuvastatin—coronary artery disease	0.00205	0.00388	CcSEcCtD
Cycloserine—Paraesthesia—Trandolapril—coronary artery disease	0.00205	0.00387	CcSEcCtD
Cycloserine—Hypersensitivity—Lovastatin—coronary artery disease	0.00204	0.00387	CcSEcCtD
Cycloserine—Paraesthesia—Enalapril—coronary artery disease	0.00204	0.00386	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CETP—coronary artery disease	0.00204	0.00432	CbGpPWpGaD
Cycloserine—Somnolence—Trandolapril—coronary artery disease	0.00203	0.00383	CcSEcCtD
Cycloserine—Somnolence—Enalapril—coronary artery disease	0.00202	0.00382	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—coronary artery disease	0.00201	0.00426	CbGpPWpGaD
Cycloserine—Feeling abnormal—Olmesartan—coronary artery disease	0.00201	0.0038	CcSEcCtD
Cycloserine—Paraesthesia—Telmisartan—coronary artery disease	0.00201	0.0038	CcSEcCtD
Cycloserine—Rash—Acetylsalicylic acid—coronary artery disease	0.00201	0.00379	CcSEcCtD
Cycloserine—Hypersensitivity—Ezetimibe—coronary artery disease	0.002	0.00379	CcSEcCtD
Cycloserine—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.002	0.00379	CcSEcCtD
Cycloserine—Confusional state—Losartan—coronary artery disease	0.002	0.00378	CcSEcCtD
Cycloserine—Somnolence—Telmisartan—coronary artery disease	0.00199	0.00376	CcSEcCtD
Cycloserine—Paraesthesia—Captopril—coronary artery disease	0.00195	0.0037	CcSEcCtD
Cycloserine—Tremor—Ramipril—coronary artery disease	0.00195	0.00369	CcSEcCtD
Cycloserine—Somnolence—Captopril—coronary artery disease	0.00193	0.00366	CcSEcCtD
Cycloserine—Feeling abnormal—Pravastatin—coronary artery disease	0.00193	0.00366	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.00193	0.00409	CbGpPWpGaD
Cycloserine—Hypersensitivity—Simvastatin—coronary artery disease	0.00191	0.00362	CcSEcCtD
Cycloserine—Paraesthesia—Perindopril—coronary artery disease	0.0019	0.00359	CcSEcCtD
Cycloserine—DDC—Dopaminergic Neurogenesis—TGFB1—coronary artery disease	0.00189	0.00401	CbGpPWpGaD
Cycloserine—Somnolence—Perindopril—coronary artery disease	0.00188	0.00355	CcSEcCtD
Cycloserine—Feeling abnormal—Trandolapril—coronary artery disease	0.00188	0.00355	CcSEcCtD
Cycloserine—Vertigo—Ramipril—coronary artery disease	0.00187	0.00354	CcSEcCtD
Cycloserine—Feeling abnormal—Enalapril—coronary artery disease	0.00187	0.00354	CcSEcCtD
Cycloserine—Paraesthesia—Furosemide—coronary artery disease	0.00184	0.00349	CcSEcCtD
Cycloserine—Feeling abnormal—Telmisartan—coronary artery disease	0.00184	0.00349	CcSEcCtD
Cycloserine—Vertigo—Timolol—coronary artery disease	0.00183	0.00346	CcSEcCtD
Cycloserine—Somnolence—Furosemide—coronary artery disease	0.00183	0.00346	CcSEcCtD
Cycloserine—Hypersensitivity—Valsartan—coronary artery disease	0.00181	0.00342	CcSEcCtD
Cycloserine—Convulsion—Ramipril—coronary artery disease	0.0018	0.00341	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.00179	0.00381	CbGpPWpGaD
Cycloserine—Feeling abnormal—Captopril—coronary artery disease	0.00179	0.00339	CcSEcCtD
Cycloserine—Rash—Fenofibrate—coronary artery disease	0.00179	0.00339	CcSEcCtD
Cycloserine—Dermatitis—Fenofibrate—coronary artery disease	0.00179	0.00339	CcSEcCtD
Cycloserine—Headache—Fenofibrate—coronary artery disease	0.00178	0.00337	CcSEcCtD
Cycloserine—Paraesthesia—Losartan—coronary artery disease	0.00178	0.00337	CcSEcCtD
Cycloserine—Tremor—Lisinopril—coronary artery disease	0.00177	0.00335	CcSEcCtD
Cycloserine—Somnolence—Losartan—coronary artery disease	0.00176	0.00333	CcSEcCtD
Cycloserine—Rash—Clopidogrel—coronary artery disease	0.00176	0.00333	CcSEcCtD
Cycloserine—Dermatitis—Clopidogrel—coronary artery disease	0.00176	0.00333	CcSEcCtD
Cycloserine—Hypersensitivity—Niacin—coronary artery disease	0.00176	0.00332	CcSEcCtD
Cycloserine—Headache—Clopidogrel—coronary artery disease	0.00175	0.00331	CcSEcCtD
Cycloserine—Rash—Lovastatin—coronary artery disease	0.00175	0.00331	CcSEcCtD
Cycloserine—Dermatitis—Lovastatin—coronary artery disease	0.00175	0.00331	CcSEcCtD
Cycloserine—Feeling abnormal—Perindopril—coronary artery disease	0.00174	0.00329	CcSEcCtD
Cycloserine—Headache—Lovastatin—coronary artery disease	0.00174	0.00329	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.00173	0.00368	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CST3—coronary artery disease	0.00173	0.00367	CbGpPWpGaD
Cycloserine—Hypersensitivity—Pravastatin—coronary artery disease	0.00173	0.00327	CcSEcCtD
Cycloserine—Rash—Ezetimibe—coronary artery disease	0.00172	0.00325	CcSEcCtD
Cycloserine—Dermatitis—Ezetimibe—coronary artery disease	0.00171	0.00324	CcSEcCtD
Cycloserine—Confusional state—Ramipril—coronary artery disease	0.00171	0.00324	CcSEcCtD
Cycloserine—Headache—Ezetimibe—coronary artery disease	0.0017	0.00323	CcSEcCtD
Cycloserine—Vertigo—Lisinopril—coronary artery disease	0.0017	0.00321	CcSEcCtD
Cycloserine—Feeling abnormal—Furosemide—coronary artery disease	0.00169	0.0032	CcSEcCtD
Cycloserine—Rash—Eplerenone—coronary artery disease	0.00168	0.00318	CcSEcCtD
Cycloserine—Hypersensitivity—Trandolapril—coronary artery disease	0.00168	0.00318	CcSEcCtD
Cycloserine—Dermatitis—Eplerenone—coronary artery disease	0.00168	0.00317	CcSEcCtD
Cycloserine—Confusional state—Timolol—coronary artery disease	0.00168	0.00317	CcSEcCtD
Cycloserine—Hypersensitivity—Enalapril—coronary artery disease	0.00167	0.00316	CcSEcCtD
Cycloserine—Headache—Eplerenone—coronary artery disease	0.00167	0.00316	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	0.00166	0.00353	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—GCLC—coronary artery disease	0.00166	0.00352	CbGpPWpGaD
Cycloserine—Hypersensitivity—Telmisartan—coronary artery disease	0.00165	0.00312	CcSEcCtD
Cycloserine—Rash—Simvastatin—coronary artery disease	0.00164	0.0031	CcSEcCtD
Cycloserine—Dermatitis—Simvastatin—coronary artery disease	0.00163	0.00309	CcSEcCtD
Cycloserine—Feeling abnormal—Losartan—coronary artery disease	0.00163	0.00309	CcSEcCtD
Cycloserine—Headache—Simvastatin—coronary artery disease	0.00163	0.00308	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.00161	0.00341	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—F7—coronary artery disease	0.00155	0.0033	CbGpPWpGaD
Cycloserine—Confusional state—Lisinopril—coronary artery disease	0.00155	0.00294	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—PSMA6—coronary artery disease	0.00155	0.00329	CbGpPWpGaD
Cycloserine—DDC—Amino acid and derivative metabolism—PSMB5—coronary artery disease	0.00155	0.00329	CbGpPWpGaD
Cycloserine—Rash—Valsartan—coronary artery disease	0.00155	0.00292	CcSEcCtD
Cycloserine—Dermatitis—Valsartan—coronary artery disease	0.00154	0.00292	CcSEcCtD
Cycloserine—Rash—Olmesartan—coronary artery disease	0.00154	0.00291	CcSEcCtD
Cycloserine—Dermatitis—Olmesartan—coronary artery disease	0.00154	0.00291	CcSEcCtD
Cycloserine—Headache—Valsartan—coronary artery disease	0.00154	0.0029	CcSEcCtD
Cycloserine—Headache—Olmesartan—coronary artery disease	0.00153	0.00289	CcSEcCtD
Cycloserine—Paraesthesia—Ramipril—coronary artery disease	0.00153	0.00289	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—PLG—coronary artery disease	0.00153	0.00324	CbGpPWpGaD
Cycloserine—Hypersensitivity—Furosemide—coronary artery disease	0.00151	0.00286	CcSEcCtD
Cycloserine—Somnolence—Ramipril—coronary artery disease	0.00151	0.00286	CcSEcCtD
Cycloserine—Rash—Niacin—coronary artery disease	0.0015	0.00284	CcSEcCtD
Cycloserine—Dermatitis—Niacin—coronary artery disease	0.0015	0.00284	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—GOT2—coronary artery disease	0.0015	0.00318	CbGpPWpGaD
Cycloserine—Headache—Niacin—coronary artery disease	0.00149	0.00282	CcSEcCtD
Cycloserine—Paraesthesia—Timolol—coronary artery disease	0.00149	0.00282	CcSEcCtD
Cycloserine—Rash—Pravastatin—coronary artery disease	0.00148	0.0028	CcSEcCtD
Cycloserine—Dermatitis—Pravastatin—coronary artery disease	0.00148	0.0028	CcSEcCtD
Cycloserine—Somnolence—Timolol—coronary artery disease	0.00148	0.00279	CcSEcCtD
Cycloserine—Headache—Pravastatin—coronary artery disease	0.00147	0.00278	CcSEcCtD
Cycloserine—Hypersensitivity—Losartan—coronary artery disease	0.00146	0.00276	CcSEcCtD
Cycloserine—Rash—Trandolapril—coronary artery disease	0.00144	0.00272	CcSEcCtD
Cycloserine—Dermatitis—Trandolapril—coronary artery disease	0.00144	0.00272	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.00143	0.00304	CbGpPWpGaD
Cycloserine—Rash—Enalapril—coronary artery disease	0.00143	0.00271	CcSEcCtD
Cycloserine—Dermatitis—Enalapril—coronary artery disease	0.00143	0.0027	CcSEcCtD
Cycloserine—Headache—Trandolapril—coronary artery disease	0.00143	0.0027	CcSEcCtD
Cycloserine—Headache—Enalapril—coronary artery disease	0.00142	0.00269	CcSEcCtD
Cycloserine—Rash—Telmisartan—coronary artery disease	0.00141	0.00267	CcSEcCtD
Cycloserine—Dermatitis—Telmisartan—coronary artery disease	0.00141	0.00267	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.00141	0.00299	CbGpPWpGaD
Cycloserine—Headache—Telmisartan—coronary artery disease	0.0014	0.00265	CcSEcCtD
Cycloserine—Feeling abnormal—Ramipril—coronary artery disease	0.0014	0.00265	CcSEcCtD
Cycloserine—Paraesthesia—Lisinopril—coronary artery disease	0.00138	0.00262	CcSEcCtD
Cycloserine—Rash—Captopril—coronary artery disease	0.00137	0.0026	CcSEcCtD
Cycloserine—Dermatitis—Captopril—coronary artery disease	0.00137	0.00259	CcSEcCtD
Cycloserine—Somnolence—Lisinopril—coronary artery disease	0.00137	0.00259	CcSEcCtD
Cycloserine—Feeling abnormal—Timolol—coronary artery disease	0.00137	0.00259	CcSEcCtD
Cycloserine—Headache—Captopril—coronary artery disease	0.00136	0.00258	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—APOB—coronary artery disease	0.00135	0.00286	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.00134	0.00285	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.00134	0.00284	CbGpPWpGaD
Cycloserine—Rash—Perindopril—coronary artery disease	0.00133	0.00252	CcSEcCtD
Cycloserine—Dermatitis—Perindopril—coronary artery disease	0.00133	0.00252	CcSEcCtD
Cycloserine—Headache—Perindopril—coronary artery disease	0.00132	0.0025	CcSEcCtD
Cycloserine—Rash—Furosemide—coronary artery disease	0.0013	0.00245	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—GOT1—coronary artery disease	0.0013	0.00275	CbGpPWpGaD
Cycloserine—Dermatitis—Furosemide—coronary artery disease	0.00129	0.00245	CcSEcCtD
Cycloserine—Headache—Furosemide—coronary artery disease	0.00129	0.00243	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—HTR7—coronary artery disease	0.00128	0.00272	CbGpPWpGaD
Cycloserine—Feeling abnormal—Lisinopril—coronary artery disease	0.00127	0.0024	CcSEcCtD
Cycloserine—DDC—Metabolism—CA5B—coronary artery disease	0.00126	0.00268	CbGpPWpGaD
Cycloserine—Hypersensitivity—Ramipril—coronary artery disease	0.00125	0.00237	CcSEcCtD
Cycloserine—Rash—Losartan—coronary artery disease	0.00125	0.00236	CcSEcCtD
Cycloserine—Dermatitis—Losartan—coronary artery disease	0.00125	0.00236	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.00125	0.00265	CbGpPWpGaD
Cycloserine—Headache—Losartan—coronary artery disease	0.00124	0.00235	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.00124	0.00263	CbGpPWpGaD
Cycloserine—Hypersensitivity—Timolol—coronary artery disease	0.00122	0.00232	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.00121	0.00256	CbGpPWpGaD
Cycloserine—Hypersensitivity—Lisinopril—coronary artery disease	0.00114	0.00215	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.0011	0.00233	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.00109	0.00232	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CKMT1B—coronary artery disease	0.00107	0.00228	CbGpPWpGaD
Cycloserine—Rash—Ramipril—coronary artery disease	0.00107	0.00203	CcSEcCtD
Cycloserine—Dermatitis—Ramipril—coronary artery disease	0.00107	0.00203	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.00107	0.00226	CbGpPWpGaD
Cycloserine—Headache—Ramipril—coronary artery disease	0.00106	0.00201	CcSEcCtD
Cycloserine—DDC—Circadian rythm related genes—SIRT1—coronary artery disease	0.00106	0.00224	CbGpPWpGaD
Cycloserine—Rash—Timolol—coronary artery disease	0.00105	0.00198	CcSEcCtD
Cycloserine—Dermatitis—Timolol—coronary artery disease	0.00105	0.00198	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.00105	0.00222	CbGpPWpGaD
Cycloserine—Headache—Timolol—coronary artery disease	0.00104	0.00197	CcSEcCtD
Cycloserine—Rash—Lisinopril—coronary artery disease	0.000972	0.00184	CcSEcCtD
Cycloserine—Dermatitis—Lisinopril—coronary artery disease	0.000971	0.00184	CcSEcCtD
Cycloserine—Headache—Lisinopril—coronary artery disease	0.000966	0.00183	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000877	0.00186	CbGpPWpGaD
Cycloserine—DDC—Metabolism—UQCRFS1—coronary artery disease	0.000875	0.00186	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPAP2B—coronary artery disease	0.000875	0.00186	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CKM—coronary artery disease	0.000875	0.00186	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.000856	0.00181	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000845	0.00179	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—LEP—coronary artery disease	0.000834	0.00177	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PYGM—coronary artery disease	0.000814	0.00173	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDH6A1—coronary artery disease	0.000814	0.00173	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SULT4A1—coronary artery disease	0.000814	0.00173	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PDK4—coronary artery disease	0.000814	0.00173	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CKMT2—coronary artery disease	0.000814	0.00173	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NOS2—coronary artery disease	0.000777	0.00165	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PPARG—coronary artery disease	0.000726	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LDHA—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMGCS2—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GYG1—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GK—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PFKM—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GATM—coronary artery disease	0.000725	0.00154	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—GSK3B—coronary artery disease	0.000722	0.00153	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CREB1—coronary artery disease	0.000716	0.00152	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GCH1—coronary artery disease	0.000692	0.00147	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AK1—coronary artery disease	0.000692	0.00147	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	0.000679	0.00144	CbGpPWpGaD
Cycloserine—DDC—Metabolism—UGCG—coronary artery disease	0.000663	0.00141	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPAT—coronary artery disease	0.000663	0.00141	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLCD1—coronary artery disease	0.000663	0.00141	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MDH2—coronary artery disease	0.000663	0.00141	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—SERPINE1—coronary artery disease	0.000654	0.00139	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1B—coronary artery disease	0.000651	0.00138	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—coronary artery disease	0.000649	0.00138	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PGM1—coronary artery disease	0.000639	0.00135	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PYGB—coronary artery disease	0.000617	0.00131	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CKB—coronary artery disease	0.000617	0.00131	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PFKFB3—coronary artery disease	0.00058	0.00123	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLIN1—coronary artery disease	0.00058	0.00123	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM2—coronary artery disease	0.00058	0.00123	CbGpPWpGaD
Cycloserine—DDC—Metabolism—COX5B—coronary artery disease	0.00058	0.00123	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DLAT—coronary artery disease	0.00058	0.00123	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	0.000551	0.00117	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SULT1E1—coronary artery disease	0.00055	0.00117	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HK2—coronary artery disease	0.000524	0.00111	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKR1B1—coronary artery disease	0.000524	0.00111	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC27A1—coronary artery disease	0.000503	0.00107	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LCAT—coronary artery disease	0.000493	0.00105	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CPT1B—coronary artery disease	0.000493	0.00105	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOA4—coronary artery disease	0.000484	0.00103	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—coronary artery disease	0.000472	0.001	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PDHA1—coronary artery disease	0.000467	0.000991	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GCLM—coronary artery disease	0.000467	0.000991	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP11B2—coronary artery disease	0.000453	0.00096	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TXNRD1—coronary artery disease	0.000453	0.00096	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC22A3—coronary artery disease	0.000446	0.000946	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HADH—coronary artery disease	0.000439	0.000932	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ARNTL—coronary artery disease	0.000439	0.000932	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOA2—coronary artery disease	0.000417	0.000884	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLA2G2A—coronary artery disease	0.000417	0.000884	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX2—coronary artery disease	0.000417	0.000884	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SULT1A1—coronary artery disease	0.000412	0.000873	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCG5—coronary artery disease	0.000412	0.000873	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HK1—coronary artery disease	0.000412	0.000873	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX4—coronary artery disease	0.000412	0.000873	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HADHA—coronary artery disease	0.000407	0.000862	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTA1—coronary artery disease	0.000402	0.000852	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LPA—coronary artery disease	0.000397	0.000843	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLCB3—coronary artery disease	0.000385	0.000816	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6—coronary artery disease	0.000381	0.000808	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOA5—coronary artery disease	0.000381	0.000808	CbGpPWpGaD
Cycloserine—DDC—Metabolism—P4HB—coronary artery disease	0.000374	0.000793	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLA2G1B—coronary artery disease	0.000367	0.000778	CbGpPWpGaD
Cycloserine—DDC—Metabolism—VCAN—coronary artery disease	0.000346	0.000733	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDOA—coronary artery disease	0.000343	0.000728	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DCN—coronary artery disease	0.000333	0.000706	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALDH2—coronary artery disease	0.000324	0.000687	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LIPC—coronary artery disease	0.000316	0.00067	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HBA1—coronary artery disease	0.000316	0.00067	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2C19—coronary artery disease	0.000316	0.00067	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3C2A—coronary artery disease	0.000316	0.00067	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOC3—coronary artery disease	0.000314	0.000666	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LDLR—coronary artery disease	0.000312	0.000661	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—IL6—coronary artery disease	0.000311	0.00066	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SLC9A1—coronary artery disease	0.000308	0.000654	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTT1—coronary artery disease	0.000308	0.000654	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CETP—coronary artery disease	0.000305	0.000646	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GCLC—coronary artery disease	0.000305	0.000646	CbGpPWpGaD
Cycloserine—DDC—Metabolism—SDC1—coronary artery disease	0.000301	0.000639	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PSMA6—coronary artery disease	0.000285	0.000604	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PSMB5—coronary artery disease	0.000285	0.000604	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CTGF—coronary artery disease	0.000278	0.00059	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMGCR—coronary artery disease	0.000275	0.000584	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GOT2—coronary artery disease	0.000275	0.000584	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLCB1—coronary artery disease	0.000253	0.000537	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCA1—coronary artery disease	0.000246	0.000521	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GGT1—coronary artery disease	0.000238	0.000504	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GOT1—coronary artery disease	0.000238	0.000504	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTP1—coronary artery disease	0.000214	0.000453	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPARGC1A—coronary artery disease	0.000212	0.000449	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMOX1—coronary artery disease	0.000211	0.000447	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CAT—coronary artery disease	0.000208	0.000441	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOB—coronary artery disease	0.000202	0.000428	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GSTM1—coronary artery disease	0.000196	0.000416	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LPL—coronary artery disease	0.000193	0.000409	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GPX1—coronary artery disease	0.000188	0.000399	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CD36—coronary artery disease	0.000183	0.000388	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPP2CA—coronary artery disease	0.000181	0.000383	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—coronary artery disease	0.000173	0.000368	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AGT—coronary artery disease	0.000165	0.00035	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOE—coronary artery disease	0.000162	0.000343	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOA1—coronary artery disease	0.00016	0.000339	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPARG—coronary artery disease	0.000141	0.000298	CbGpPWpGaD
Cycloserine—DDC—Metabolism—POMC—coronary artery disease	0.000139	0.000294	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ALB—coronary artery disease	0.000126	0.000268	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NOS3—coronary artery disease	0.000121	0.000257	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS2—coronary artery disease	0.000111	0.000235	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PIK3CA—coronary artery disease	6.81e-05	0.000144	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKT1—coronary artery disease	5.56e-05	0.000118	CbGpPWpGaD
